V. Balyazin

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Cerebral bioelectric activity in patients with classical trigeminal neuralgia before and after conservative treatment

O. M. Evusyak, V. Balyazin, E. V. Balyazina, 2021 .

Russian multicenter study of fixed combination of diclofenac and orphenadrine its efficacy and tolerance of in acute non-specific pain and radiculopathy relief

O. S. Davydov, O. Kurushina, A. Amelin, 2022, Russian Journal of Pain.